face

How biotechs cut corners in process development – without compromising quality

Discover just how much you can benefit from using mass spectrometry for HCP Host Cell Protein analysis and ELISA coverage analysis in these video cases.

Video episodes

h

Quantification of viral, bovine, and human proteins

Analysis of a product utilizing a lentiviral vector expressed in HEK 293 T cells

 Go to video
h

Investigating HCPs in mAbs using a native digest

A native digest approach lowered LOD - to reveal potentially problematic HCPs

 Go to video
h

HCP purification optimization - from harvest to final DS

Optimization of purification process using PI and MW data of each HCP

 Go to video
h

Comparison of HCP removal strategies

Evaluation of HCPs after 3 different combinations of purification steps

 Go to video
h

Qualification report used for IND application

First example of regulatory authorities accepting IND without ELISA data

 Go to video
h

HCP coverage analysis using immunocapture and LC-MS

Measuring the coverage of your HCP ELISA when without a null cell line

 Go to video
h

Convincing documentation of HCP Clearance in PPQ runs

Comparing the consistency of PPQ runs and following specific Host Cell Proteins

 Go to video
h

Problems with non-dilutional linearity of ELISA

This biotech company had issues with the validation of its ELISA

 Go to video
h

HCP analysis for uncommon expression systems

What to do, when no commercial ELISA kit fits your expression system

 Go to video
h

mAb biosimilar was cleaner than the originator

Investigation of why one mAb biosimilar was more stable than the originator

 Go to video

Learn more:

© Copyright Alphalyse 2002 - 2021. All rights reserved.